Tag: Africa

Roll Out of Anshin Data Box Powered by Synchronoss Personal Cloud Integrates Artificial Intelligence Functionality and Enables Customers to Optimize, Organize, and Safeguard Photos, Videos, and Other Digital Content

BRIDGEWATER, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging, and digital products and platforms, today announced that SoftBank Corp. (“SoftBank”), one of Japan’s largest telecommunication carriers, has deployed Synchronoss Personal Cloud to power its Anshin Data Box service.

Anshin Data Box allows customers to backup and restore photos, videos, and files stored on mobile phones and other devices. Additionally, the platform’s artificial intelligence features provide the capability to optimize low resolution photos and create new types of content through a series of effects and stylizers.

Available in November across multiple distribution channels, SoftBank’s Anshin Data Box will include 500 gigabytes of storage per month. Additionally, the personal cloud service will be integrated into new devices, allowing customers to easily activate it during the onboarding process. SoftBank will also deliver Anshin Data Box through its retail stores and digital buy flow.

“We continue to empower telecom operators and mobile service providers with strategic tools to improve customer value,” said Jeff Miller, President and CEO of Synchronoss. “This new Cloud launch with SoftBank further extends our long-standing relationship with them and our presence in Japan. It also reinforces our cloud-first strategy, which represents new growth opportunities for the Synchronoss Personal Cloud platform.”

About Synchronoss
Synchronoss Technologies (Nasdaq: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding, and engage subscribers to unleash new revenue streams, reduce costs, and increase speed to market. Hundreds of millions of subscribers trust Synchronoss products to stay in sync with the people, services, and content they love. Learn more at www.synchronoss.com.

Media Relations Contact:
Domenick Cilea
Springboard
dcilea@springboardpr.com

Investor Relations Contact:
Matt Glover and Tom Colton
Gateway Group, Inc.
SNCR@gateway-grp.com

GlobeNewswire Distribution ID 8968023

RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — In a groundbreaking development for the Middle East, King Faisal Specialist Hospital and Research Centre (KFSH&RC) has introduced a service called Rapid Whole-Genome Sequencing (rWGS) as part of its healthcare solutions. This service is designed to help doctors diagnose rare and genetic disorders, particularly in critically ill newborns, who require fast and precise identification of their conditions.

The Rapid Whole Genome Sequencing service is invaluable for newborns with rare diseases, as it helps them avoid the often lengthy process of tests and treatments that can stretch for months or even years without a precise diagnosis. This increases the chances of survival and reduces the overall healthcare cost by minimizing hospital admissions, unnecessary tests, and medical care.

KFSH&RC Rapid Whole Genome Sequencing _ 02

Remarkably, the hospital has reduced the time required for this genetic testing from the typical two-month duration to less than 35 hours. Response time is paramount when planning healthcare for critically ill newborns, and swift delivery of test results ensures a prompt and tailored medical response, preventing delays that could otherwise lead to worsening the patient’s condition or even death.

As part of its participation in the Global Health Summit, where KFSH&RC plays a vital role as a strategic healthcare partner, the hospital shares details about the Rapid Whole Genome Sequencing service at its exhibition booth. The hospital’s cutting-edge capabilities include analyzing up to 99% of DNA sequences from patient blood samples, along with several innovative healthcare solutions.

The comprehensive genetic composition examination involves a streamlined four-step process. First, the DNA is broken down into manageable segments. Then, it is encoded with a barcode-like symbol for easy identification, similar to tracking products in a store. The examination itself is conducted using specialized equipment. Finally, advanced computer systems and software compare these sequences, identifying differences in DNA sequences and pinpointing the genetic mutations responsible for diseases.

KFSH&RC provides the highest level of healthcare and offers the best possible patient experience within an integrated educational and research environment. It collaborates and shares expertise with leading local, regional, and international institutions to provide a globally competitive service in clinical, research, and educational fields.

Globally renowned for its specialized healthcare, KFSH&RC is a pioneer in medical innovation and a hub for advanced medical research and education. It is committed to advancing medical technologies and raising the standard of healthcare worldwide through partnerships with top local, regional, and international institutions in clinical, research, and educational sectors.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/59bc8aa4-5f6d-432a-b4e9-c26544e9aa6d

https://www.globenewswire.com/NewsRoom/AttachmentNg/76f80d26-8e56-42df-b95a-c8cdab80e449

GlobeNewswire Distribution ID 8968201

Bed waiting time reduced from 32 hours to 6 hours

RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — Healthcare providers are facing a continuous increase in the demand for healthcare services, necessitating a redirection of efforts towards improving the operational efficiency of healthcare institutions. In response to this challenge that healthcare providers worldwide face, the Capacity Command Center in King Faisal Specialist Hospital and Research Centre (KFSH&RC) has emerged as a pioneer in enhancing operational efficiency by implementing globally recognized procedures. It essentially aims to improve overall healthcare outcomes in alignment with the goals of Saudi Vision 2030.

Since its launch in September 2021, the Center has executed over 170,000 intervention procedures, significantly reducing bed waiting times from 32 hours to 6 hours. The emergency department has also seen a 14% reduction in waiting times. Furthermore, waiting times in the pharmacy and laboratory have improved, with over 90% of beneficiaries receiving services in less than 15 minutes.

Since its establishment, the Center has become the primary source for data-driven decision-making, it continuously monitors patient movements to maintain care quality, adhere to standard operating procedures, and predict demand volumes to mitigate risks and address potential challenges.

KFSH&RC’s Capacity Command Center is a Pioneering Model for Achieving Maximum Operational Efficiency_01

Simultaneously, as a strategic health partner at the Global Health Exhibition in Riyadh from October 29-31, KFSH&RC showcases its mechanisms for improving operational efficiency, healthcare outcomes, and the patient experience, positioning itself as a leading healthcare solution in the region.

The Capacity Command Center relies on a strategy that adjusts business plans and interventions based on evidence-based practices driven by artificial intelligence to improve workflow mapping and planning. The Center’s services include technical reporting, data mining, operational performance enhancement, and review processes and plans, culminating in regular report issuance.

This Center is part of KFSH&RC’s ongoing efforts to harness all resources and bring the latest technologies to improve outcomes and operational efficiency. It aims to be the optimal choice for every patient seeking specialized healthcare services, making these services accessible to a broader range of beneficiaries.

KFSH&RC is globally renowned for providing specialized healthcare and is a pioneer in innovation, advanced medical research, and medical education. The institution actively seeks to develop medical technologies and enhance the standard of healthcare worldwide, collaborating with leading local, regional, and international organizations to deliver world-class services in clinical, research, and educational domains.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fe240c06-779b-48f8-bf90-542602be547f

https://www.globenewswire.com/NewsRoom/AttachmentNg/879c9435-ea23-47f2-b81a-240a1e2bb3a5

GlobeNewswire Distribution ID 8968149

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its pioneering journey and prospects in space biomedical research and its role in enhancing human health at the Global Health Exhibition, where KFSH&RC is also participating as a strategic healthcare partner.

At the Exhibition, KFSH&RC delves into its groundbreaking experience leading four research experiments in cell sciences in space. These experiments encompass testing the immune cell response to inflammation in space, monitoring the activity of thousands of genes in immune cells exposed to inflammation over time, and tracking the changes in the lifespan of ribonucleic acid (mRNA) between space and Earth. Additionally, the pavilion simulates the inflammatory response to drug treatment using an immune cell model to explore its potential applications for prevention and early treatment.

The aim of these research experiments, conducted in collaboration with the Saudi Space Authority, as part of the scientific mission of Saudi astronauts Rayyanah Barnawi and Ali Al-Qarni to the International Space Station (ISS), is to contribute to exploratory research and its applications in space medicine to enhance the safety of space explorers and utilize the knowledge gained for the benefit the patient community globally.

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition

The scientific experiments lasted for four days and were overseen by the research team led by Dr. Khaled Saad Abu Khubrah, Head of the Department of Molecular Biomedicine and Research at KFSH&RC, along with Dr. Wijdan Al-Ahmadi from KFSH&RC and Dr. Edward Hattie from the BioServe Space Technologies Center in Colorado, USA.

KFSH&RC is actively pursuing further research in space biomedical science to gain a more comprehensive understanding of the effects of gravity deficiency and cosmic radiation on the human body. They aim to leverage the unique space environment, which provides opportunities for medical experiments that are not feasible on Earth. This includes studying how cells and tissues grow in microgravity conditions, potentially leading to groundbreaking discoveries in disease treatments and opening new avenues in space medicine.

KFSH&RC is globally renowned for its specialized healthcare services and its leadership in innovation. It stands as an advanced centre for medical research and education, aiming to advance medical technologies and raise the standard of healthcare worldwide through partnerships with prominent local, regional, and international institutions in clinical, research, and educational fields.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/78eba5fa-19d6-437c-ab42-c9a09636e91e

https://www.globenewswire.com/NewsRoom/AttachmentNg/c30c198b-dd13-4d48-8b8c-6667eda49b45

GlobeNewswire Distribution ID 8967907

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) — In a historic achievement, the Organ Transplant Center of Excellence (OTCoE) team at King Faisal Specialist Hospital & Research Centre (KFSH&RC) has successfully performed the world’s first fully robotic living donor liver transplant in the Kingdom of Saudi Arabia—a move that solidifies KFSH&RC’s position as a global leader in minimally invasive transplant surgery.

KFSH&RC’s pioneering approach employed state-of-the-art robotic technology to conduct both donor and recipient surgeries with precision and minimal invasiveness, eliminating the need for a hybrid approach. While other centres offer minimally invasive liver transplants using mixed techniques, KFSH&RC is the only centre to complete a fully robotic living donor liver transplant surgery successfully.

This accomplishment represents a significant leap forward in the history of transplantation, a testament to the centre’s commitment to advanced practices that enhance healthcare outcomes, improve the patient experience, and boost hospital operational efficiency. It has also led to a reduction in the risk of complications, recovery time, and the length of hospital stays.

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World’s First Fully Robotic Living Donor Liver Transplant

As a strategic health partner at the Global Health Exhibition held in Riyadh from October 29 to October 31, KFSH&RC is showcasing its latest innovations at the forum. Attendees will gain insights into the OTCoE’s expertise in applying cutting-edge technologies to expand healthcare possibilities.

KFSH&RC has set records in successfully conducting reciprocal kidney transplants, a medical approach that facilitates kidney transplants between two donors from different families simultaneously. In 2022, the program achieved a remarkable milestone by completing 91 reciprocal transplants, surpassing its international counterparts.

KFSH&RC’s OTCoE is a pioneer in the Kingdom, representing one of the most advanced and comprehensive facilities for multi-organ transplantation in the Middle East. Its services encompass kidney, liver, lung, pancreas, and intestine transplants, collectively called solid organ transplantation.

KFSH&RC is globally renowned for its exceptional contributions to specialized healthcare, commitment to innovation, and dedication to advanced medical research and education. Furthermore, KFSH&RC is steadfast in its pursuit of developing medical technologies and elevating the standard of healthcare globally by collaborating with major local, regional, and international institutions. It is committed to delivering world-class clinical, research, and educational services.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/888a9b0a-3cd2-4186-ab5e-b44eb8f0d9cb

https://www.globenewswire.com/NewsRoom/AttachmentNg/250c97ba-0d78-4a24-83a5-73e063b3366b

GlobeNewswire Distribution ID 8967901

RIYADH, Saudi Arabia, Oct. 28, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is participating as a strategic health partner in the Global Health Exhibition 2023, which begins in Riyadh tomorrow and continues for three days.

The hospital, through its pavilion participating in the exhibition accompanying the forum, will showcase its most prominent innovations and health solutions within the framework of its strategic directions aimed at strengthening its position as a pioneer of knowledge through education, research, innovation, and providing health care with the highest levels of quality and safety.

His Excellency the CEO of King Faisal Specialist Hospital and Research Centre, Dr. Majid Ibrahim Al Fayyadh, stated on this occasion: The Kingdom of Saudi Arabia is working to consolidate its position as a global leader in the field of innovation, fostering a dynamic ecosystem that embraces the latest technologies, supporting the future of healthcare, and establishing it as a worldwide destination.

Dr Majid Ibrahim Al Fayyadh stressed that KFSH&RC’s participation in the exhibition comes in the context of its commitment to advancing innovation in the health sector from the national to the global level and supporting everything that contributes to providing the highest levels of healthcare and the best patient experience.

KFSH&RC introduces visitors of the exhibition to its various health innovations and solutions and their impact on enhancing health care outcomes and patient experience and improving operating efficiency in multiple medical fields, including the patient journey, space biomedical research, genomic medicine, capacity management, radiopharmaceutical drug production, and treatment, with T cells (CAR-T Cell).

KFSH&RC is poised to exhibit its innovations, demonstrating its leadership in biomedical space research. This is underscored by its leadership in overseeing four research experiments in cell sciences conducted in space, solidifying the hospital’s pioneering role in fostering international innovation. Additionally, the hospital will present its T-cell re-engineering treatment program for cancer patients, signifying a significant enhancement in specialized medical care within the Kingdom. This advancement also translates to reduced financial and health burdens, as patients are no longer required to seek treatment abroad.

KFSH&RC is considered among the most prominent in the world in providing specialized health care, a pioneer in innovation, and an advanced medical research and education center. It also seeks to develop medical technologies and raise health care worldwide in partnership with major local, regional, and international institutions, to achieve world-class service in the clinical, research, and educational fields.

Contact information:
kfshrc@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5b3530bb-ea2d-42ee-a358-4c2fe3f8630e

GlobeNewswire Distribution ID 8967812